• 2022-02-18 07:59:52

When there is a threat of public health emergencies, and after the occurrence of public health emergencies, NMPA shall implement emergency review and approval for medical devices required for emergency handling of public health emergencies in accordance with the principles of unified command, early intervention, on-call review, and scientific approval.

• 2022-01-26 08:31:11

Clinical trial data is one of the important supporting documents for evaluating the safety and effectiveness of medical devices. Standardizing the collection, sorting, analysis, and submission of medical device clinical trial data will not only improve the quality of clinical trial implementation and management but also assist the regulatory agency to understand and review the development of clinical trials quickly and efficiently.

• 2021-12-27 06:33:04

Qualtech Consulting would like to invite you to our free online Webinar on the subject of "New CER Requirements in China". Our event is scheduled to be held on January 21st (Friday), 2022.

• 2021-12-27 04:54:37

NMPA has issued a new regulation of the “Management Provision on the Self-Testing for Medical Device Registration” which include the requirements for manufacturer’s capacity for self-testing, quality management system, self-testing report and related responsibilities.

• 2021-10-27 07:01:31

In order to strengthen the supervision and guidance of the registration for medical device and further improve the quality of registration review, NMPA has published a new guidance document focusing on equivalence demonstration in clinical evaluation report of intravascular catheters.

• 2021-10-27 05:29:58

The “Administrative Measures for the Registration and Filing of Medical Devices” have been adopted at the 11th executive meeting of the State Administration for Market Regulation on July 22, 2021. The measures have subsequently been promulgated and have come into effect on October 1, 2021 via Decree No. 47.

• 2021-09-30 07:43:02

On July 22, 2021, the China State Administration for Market Regulation has released a new version of the "Administrative Measures for the Registration and Filing of Medical Devices", which will be executed and come into effect on October 1, 2021.

• 2021-09-29 00:25:11

In order to further standardize the generic names of medical devices and strengthen the management of the whole life cycle of medical devices, NMPA has organized and formulated six naming guidelines.

• 2021-08-30 01:11:33

The Medical Device Division (MDD) will continue the trial to study the feasibility for Local Responsible Persons (LRP) to prove their medical device conform the “Essential Principles of Safety and Performance of Medical Devices” by providing marketing approval from China's National Medical Products Administration (NMPA) and Korea's Ministry of Food and Drug Safety (MFDS).

• 2021-08-26 11:37:06

Following extensive consultation, China's Center for Medical Device Evaluation (CMDE) has issued guidelines for artificial intelligence medical software product classification and definition.